These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36112665)

  • 21. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men.
    Zhu M; Babar M; Hawks-Ladds N; Tawfik MM; Loloi J; Labagnara K; Sayed R; Tang K; Salami A; Singh S; Singh J; Ines M; Iqbal N; Ciatto M
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):109-115. PubMed ID: 37620427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of 160 W Greenlight laser vaporization of the prostate on erectile function: a prospective randomized controlled trial with 1-year follow-up.
    Ouyang Y; Liu C; Guan W; Zhao Y; Xu Y; Wu Y
    Photomed Laser Surg; 2014 Aug; 32(8):463-7. PubMed ID: 25101536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported outcomes after buccal mucosal graft urethroplasty for bulbar urethral strictures: results of a prospective single-centre cohort study.
    D'hulst P; Muilwijk T; Vander Eeckt K; Van der Aa F; Joniau S
    BJU Int; 2020 Dec; 126(6):684-693. PubMed ID: 32512634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
    J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis.
    Kallidonis P; Adamou C; Kotsiris D; Ntasiotis P; Verze P; Athanasopoulos A;
    Eur Urol Focus; 2020 May; 6(3):537-558. PubMed ID: 31133414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
    Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
    World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
    Sebastianelli A; Spatafora P; Frizzi J; Saleh O; De Nunzio C; Tubaro A; Vignozzi L; Maggi M; Serni S; McVary KT; Kaplan SA; Gravas S; Chapple C; Gacci M
    Eur Urol Focus; 2021 Mar; 7(2):432-439. PubMed ID: 31606473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
    Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
    Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
    Bechara A; Romano S; Casabé A; Haime S; Dedola P; Hernández C; Rey H
    J Sex Med; 2008 Sep; 5(9):2170-8. PubMed ID: 18638006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.